Skye Bioscience (SKYE) Notes Payables (2013 - 2023)
Skye Bioscience (SKYE) posted quarterly Notes Payables of $11300.0 for Q3 2023, down 90.6% year-over-year from $120216.0 in Q3 2022, and down 89.57% quarter-over-quarter from $108301.0 in Q2 2023.
Skye Bioscience (SKYE) Notes Payables (2013 - 2023) Analysis & Trends
Skye Bioscience (SKYE) has reported Notes Payables for 9 consecutive years, with $11300.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Notes Payables fell 90.6% year-over-year to $11300.0; the TTM figure through Sep 2023 stood at $11300.0 (down 90.6% YoY), while the FY2022 annual figure was $124901.0, up 109.1% from the prior year.
- Notes Payables retreated to $11300.0 in Q3 2023 per SKYE's latest filing, from $108301.0 in the prior quarter.
- Across five years, Notes Payables topped out at $28.3 million in Q1 2019 and bottomed at $11300.0 in Q3 2023.
- Historically, Notes Payables has averaged $2.9 million across 5 years, with a median of $108301.0 in 2023.
- Annual changes were most pronounced in 2020 — Notes Payables sank 99.7% — and 2022, when it surged 613.11%.
- Skye Bioscience's Notes Payables stood at $410603.0 in 2019, then sank by 90.61% to $38567.0 in 2020, then jumped by 54.88% to $59732.0 in 2021, then jumped by 109.1% to $124901.0 in 2022, then sank by 90.95% to $11300.0 in 2023.
- Business Quant data shows SKYE's Notes Payables at $11300.0 in Q3 2023, $108301.0 in Q2 2023, and $104570.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Skye Bioscience | 10.72 Mn | 10.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 11,300.00 |
| Jun 30, 2023 | 108,301.00 |
| Mar 31, 2023 | 104,570.00 |
| Dec 31, 2022 | 124,901.00 |
| Sep 30, 2022 | 120,216.00 |
| Jun 30, 2022 | 107,237.00 |
| Mar 31, 2022 | 16,077.00 |
| Dec 31, 2021 | 59,732.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 15,038.00 |
| Mar 31, 2021 | 276,917.00 |
| Dec 31, 2020 | 38,567.00 |
| Sep 30, 2020 | 41,149.00 |
| Jun 30, 2020 | 465,287.00 |
| Mar 31, 2020 | 248,052.00 |
| Dec 31, 2019 | 410,603.00 |
| Sep 30, 2019 | 13.74 Mn |
| Jun 30, 2019 | 10.66 Mn |
| Mar 31, 2019 | 28.33 Mn |
| Dec 31, 2018 | 15.74 Mn |